HEARTS en las Américas: un ejemplo mundial del uso de dispositivos automatizados de medición de la presión arterial validados clínicamente en la prevención y el manejo de las enfermedades cardiovasculares en entornos de atención primaria de salud
- PMID: 35573113
- PMCID: PMC9097929
- DOI: 10.26633/RPSP.2022.50
HEARTS en las Américas: un ejemplo mundial del uso de dispositivos automatizados de medición de la presión arterial validados clínicamente en la prevención y el manejo de las enfermedades cardiovasculares en entornos de atención primaria de salud
References
-
- Martinez R, Soliz P, Mujica OJ, Reveiz L, Campbell NRC, Ordunez P. The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: a population trend analysis of 37 countries from 1990 to 2017. J Clin Hypertens (Greenwich) 2020;22:1296–309. - PMC - PubMed
- 1. Martinez R, Soliz P, Mujica OJ, Reveiz L, Campbell NRC, Ordunez P. The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: a population trend analysis of 37 countries from 1990 to 2017. J Clin Hypertens (Greenwich). 2020;22:1296–309. - PMC - PubMed
-
- Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang X-H, Khan T, et al. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens. 2019;21:1744–1752. - PMC - PubMed
- 2. Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang X-H, Khan T, et al. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens. 2019;21:1744–52. - PMC - PubMed
-
- NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–980. - PMC - PubMed
- 3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80. - PMC - PubMed
-
- Frieden TR, Varghese CV, Kishore SP, Campbell NRC, Moran AE, Padwal R, et al. Scaling up effective treatment of hypertension—a pathfinder for universal health coverage. J Clin Hypertens (Greenwich) 2019;21:1442–1449. - PMC - PubMed
- 4. Frieden TR, Varghese CV, Kishore SP, Campbell NRC, Moran AE, Padwal R, et al. Scaling up effective treatment of hypertension—a pathfinder for universal health coverage. J Clin Hypertens (Greenwich). 2019;21:1442–9. - PMC - PubMed
-
- Campbell NRC, Ordunez P, Giraldo G, Rodriguez Morales YA, Lombardi C, Khan T, et al. WHO HEARTS: a global program to reduce cardiovascular disease burden: experience implementing in the Americas and opportunities in Canada. Can J Cardiol. 2021;37:744–755. - PubMed
- 5. Campbell NRC, Ordunez P, Giraldo G, Rodriguez Morales YA, Lombardi C, Khan T, et al. WHO HEARTS: a global program to reduce cardiovascular disease burden: experience implementing in the Americas and opportunities in Canada. Can J Cardiol. 2021;37:744–55. - PubMed
LinkOut - more resources
Full Text Sources